[Controversies in therapy of bronchial asthma].
von Wichert
P
P
Zentrum für Innere Medizin, Medizinische Poliklinik, Philipps-Universität Marburg.
Feddersen
C O
CO
D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology; D016535:Bronchial Hyperreactivity / Q000188:drug therapy / Q000209:etiology; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use; D006633:Histamine Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D012130:Respiratory Hypersensitivity / Q000188:drug therapy / Q000209:etiology
D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D006633:Histamine Antagonists
Kontroversen in der Therapie des Asthma bronchiale.